Sanofi India Limited Wins Income Tax Appeal, Rs. 72.7 Lakh Demand Deleted
Sanofi India Limited received a favourable order from the Income Tax Appellate Authority, deleting a demand of ₹72.71 lakh for Assessment Year 2019-20. The appeal pertained to non-deduction of taxes on year-end provisions. The company confirmed no material impact on its financials or operations.
The company explicitly stated that there is no material impact on its financial, operational, or other activities.
The company won an income tax appeal, resulting in the deletion of a significant demand, which is a positive outcome.
Sanofi India Limited has received a favourable order from the Income Tax Department - Office of the Commissioner of Income Tax Appeal - 49, Mumbai. The appeal was filed against an order under Section 201 of the Income-tax Act, 1961, which had treated the company as an 'assessee in default' for non-deduction of taxes on year-end provisions, resulting in a demand of ₹72,71,510.
The Commissioner of Income Tax Appeal has accepted the company's submissions that since Sanofi India Limited had already made the disallowance in its tax computation, it cannot be treated as an 'assessee in default' for the same amount. Consequently, the proceedings initiated under Section 201 of the Act for Assessment Year 2019-20 have been dropped, and the demand of ₹72,71,510 has been deleted.
The order was received by the company on 02nd July 2026. Sanofi India Limited has stated that there is no material impact on its financial, operational, or other activities as a result of this order.
What to do with a filing like this
Sanofi India Limited filed this with the NSE as a statutory disclosure, categorised under taxation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sanofi India Limited. Read the original for the full detail.